Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1375 of 3173 entries
View as:

Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2

Phase: N/A Priority: Normal
NCT ID: NCT04887948 Org: User:
Start: 05/20/21 End: 12/08/21 Due: 12/08/22

A Study of PF-07258669 In Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05113940 Org: User:
Start: 11/08/21 End: 07/27/23 Due: 07/27/24

To Explore The Potential For PF-04531083 To Effect The Blood Concentrations Of Simvastatin And Its Main Acid Metabolite Following Co-Administration Of Both Medications

Phase: N/A Priority: Normal
NCT ID: NCT01103739 Org: User:
Start: 03/31/10 End: 05/31/10 Due: 05/31/11

A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01309737 Org: User:
Start: 03/31/11 End: 04/30/13 Due: 04/30/14

Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00744263 Org: User:
Start: 09/30/08 End: 10/31/13 Due: 10/31/14

A Study to Understand How the Study Medicine (PF-07976016) is Processed and Eliminated in Healthy Men

Phase: N/A Priority: Normal
NCT ID: NCT07015918 Org: User:
Start: 06/04/25 End: 08/13/25 Due: 08/13/26

Pharmacokinetics Of CP-690,550 In Patients With Impaired Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT01740362 Org: User:
Start: 10/31/03 End: 03/31/04 Due: 03/31/05

A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00141297 Org: User:
Start: 09/30/04 End: 12/31/14 Due: 12/31/15

Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years

Phase: N/A Priority: Normal
NCT ID: NCT00161746 Org: User:
Start: 04/30/98 End: 06/30/99 Due: 06/30/00

A Study In Patients Who Will Undergo Surgical Removal Of Non-Small Cell Lung Cancer To Evaluate Molecular Changes That Occur In Tumor Tissue After Short Term Exposure To PF-00299804

Phase: N/A Priority: Normal
NCT ID: NCT00971191 Org: User:
Start: 02/28/10 End: 05/31/12 Due: 05/31/13

A Trial Of SU14813 In Patients With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00982267 Org: User:
Start: 12/31/03 End: 06/30/11 Due: 06/30/12

A Study Evaluating Safety And Immunogenicity Of Meningococcal B Rlp2086 Vaccine In Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00808028 Org: User:
Start: 02/28/09 End: 03/31/14 Due: 03/31/15

A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT02364999 Org: User:
Start: 04/30/15 End: 12/31/17 Due: 12/31/18

UK Study Assessing Flexible Dose Fesoterodine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00806494 Org: User:
Start: 02/28/09 End: 01/31/10 Due: 01/31/11

Safety, Tolerability, And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00959192 Org: User:
Start: 08/31/09 End: 01/31/13 Due: 01/31/14

A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00134199 Org: User:
Start: 03/31/05 End: 11/30/05 Due: 11/30/06

Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT05158244 Org: User:
Start: 12/22/21 End: 06/15/22 Due: 06/15/23

Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT00242710 Org: User:
Start: 09/30/05 End: 09/30/08 Due: 09/30/09

A Midazolam Drug Interaction Study With PF-04171327

Phase: N/A Priority: Normal
NCT ID: NCT00987038 Org: User:
Start: 09/30/09 End: 12/31/09 Due: 12/31/10

A Study Of Celecoxib Versus Diclofenac In Patients With Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT02528201 Org: User:
Start: 09/30/02 End: 11/30/04 Due: 11/30/05

Multiple Ascending Dose Study To Assess Safety, Tolerability And Pharmacokinetics Of PF-05212377 (SAM-760)

Phase: N/A Priority: Normal
NCT ID: NCT01159496 Org: User:
Start: 07/31/10 End: 12/31/10 Due: 12/31/11

Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections.

Phase: N/A Priority: Normal
NCT ID: NCT02202135 Org: User:
Start: 06/30/14 End: 01/31/15 Due: 01/31/16

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT04382326 Org: User:
Start: 05/20/20 End: 09/02/22 Due: 09/02/23

A Study to Evaluate the Safety of Apixaban in Acute Coronary Syndrome (ACS) Japanese Patients

Phase: N/A Priority: Normal
NCT ID: NCT00852397 Org: User:
Start: 04/30/09 End: 12/31/10 Due: 12/31/11

A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05932290 Org: User:
Start: 06/01/23 End: 07/12/23 Due: 07/12/24